athenahealth, Inc. (NASDAQ:ATHN) has earned a consensus recommendation of “Hold” from the twenty-eight analysts that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $149.14.

ATHN has been the topic of a number of recent analyst reports. Citigroup Inc. reaffirmed a “buy” rating and set a $169.00 price target (up previously from $163.00) on shares of athenahealth in a research note on Monday, July 10th. BidaskClub raised shares of athenahealth from a “hold” rating to a “buy” rating in a research note on Saturday, June 24th. William Blair reissued a “market perform” rating on shares of athenahealth in a research note on Friday, July 21st. J P Morgan Chase & Co set a $136.00 target price on shares of athenahealth and gave the company a “hold” rating in a research note on Wednesday, July 19th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $135.00 target price on shares of athenahealth in a research note on Monday, June 26th.

COPYRIGHT VIOLATION NOTICE: This story was published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/09/13/athenahealth-inc-athn-given-average-recommendation-of-hold-by-brokerages.html.

In other athenahealth news, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $140.81, for a total transaction of $112,648.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jonathan Bush sold 4,000 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $140.52, for a total transaction of $562,080.00. Following the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $44,939,279.64. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,722 shares of company stock valued at $2,225,288. 3.20% of the stock is owned by company insiders.

A number of hedge funds have recently made changes to their positions in ATHN. Janus Henderson Group PLC acquired a new position in athenahealth during the 2nd quarter worth $713,856,000. BlackRock Inc. grew its holdings in athenahealth by 30,642.6% during the 1st quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after acquiring an additional 1,594,643 shares in the last quarter. Morgan Stanley grew its holdings in athenahealth by 9.7% during the 1st quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after acquiring an additional 397,837 shares in the last quarter. Elliott Management Corp acquired a new position in athenahealth during the 2nd quarter worth $52,706,000. Finally, Clearbridge Investments LLC grew its holdings in athenahealth by 61.8% during the 1st quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after acquiring an additional 347,133 shares in the last quarter.

athenahealth (NASDAQ ATHN) traded down 0.36% during mid-day trading on Wednesday, reaching $131.92. 26,845 shares of the company traded hands. The stock has a market capitalization of $5.27 billion, a PE ratio of 167.41 and a beta of 1.79. athenahealth has a 52-week low of $90.11 and a 52-week high of $158.66. The stock has a 50-day moving average of $141.02 and a 200 day moving average of $128.63.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.12. The company had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. athenahealth’s revenue was up 15.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.34 earnings per share. Equities research analysts expect that athenahealth will post $1.91 earnings per share for the current year.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.